A phase 1 dose-escalation study of GCC19 CART a novel coupled CAR therapy for subjects with metastatic colorectal cancer.

作者全名："Cui, Jiuwei; Chen, Naifei; Pu, Chengfei; Zhao, Lingling; Li, Ning; Wang, Chang; Huang, Yusheng; Luo, Suxia; Li, Xun; Yang, Zhenzhou; Bie, Jun; Zhu, Ruihong; Huang, Xi; Tang, Haiyang; Liang, Tingting; Wang, Yizhuo; Kennedy, Eugene Paul; Wu, Zhao; Song, Yongping; Xiao, Lei"

作者地址："Changchun, First Bethune Hosp, Changchun, Peoples R China; Jilin Univ, Hosp 1, Ctr Canc, Changchun, Peoples R China; Jilin Univ, Hosp 1, Stem Cell & Canc Ctr, Changchun, Peoples R China; Innovat Cellular Therapeut Co Ltd, Shanghai, Peoples R China; Jilin Univ, Bethune Hosp 1, Changchun, Peoples R China; Zhengzhou Univ & Henan Canc Ho, Afliated Canc Hosp, Zhengzhou, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Dept Canc Ctr, Chongqing, Peoples R China; Dept Oncol & Southwest Canc, Chongqing, Peoples R China; Zhengzhou Univ & Henan Canc, Affiliated Canc Hosp, Zhengzhou, Peoples R China; First Hosp Lanzhou Univ, Lanzhou, Peoples R China; Affiliated Hosp 2, Ctr Canc, Chongqing, Peoples R China; Nanchong Cent Hosp, Nanchong, Peoples R China; Innovat Cellular Thera peut, Shanghai, Peoples R China; First Hosp Jilin Univ, Changchun, Peoples R China; Innovat Cellular Therapeut, Rockville, MD USA; Henan Canc Hosp, Zhengzhou, Peoples R China"

通信作者：　

来源：JOURNAL OF CLINICAL ONCOLOGY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:000863680301123

JCR分区：Q1

影响因子：45.3

年份：2022

卷号：40

期号：16

开始页：　

结束页：　

文献类型：Meeting Abstract

关键词：　

摘要：　

基金机构：Innovative Cellular Therapeutics

基金资助正文：Innovative Cellular Therapeutics.